60 Day FRN

Federal Register / Vol. 83, No. 246 / Wednesday, December 26, 2018 / Notices
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2018–27852 Filed 12–21–18; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–19–0612; Docket No. CDC–2018–
0111]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
on the Well-Integrated Screening and
Evaluation for Women Across the
Nation (WISEWOMAN) program. The
WISEWOMAN program is designed to
prevent, detect, and control,
hypertension and other cardiovascular
disease risk factors through healthy
behavior support services, which are
tailored for individual and group
behavior change.
DATES: CDC must receive written
comments on or before February 25,
2019.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
0111 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal

amozie on DSK3GDR082PROD with NOTICES1

SUMMARY:

VerDate Sep<11>2014

20:07 Dec 21, 2018

Jkt 247001

(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
reinstatement of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Well-Integrated Screening and
Evaluation for Women Across the
Nation (WISEWOMAN) (OMB No.
0920–0612, Exp. 12/31/2018)—
Reinstatement—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).

PO 00000

Frm 00033

Fmt 4703

Sfmt 4703

66269

Background and Brief Description
The WISEWOMAN program
sponsored by the CDC, provides services
to low income, uninsured, or
underinsured women aged 40–64. The
WISEWOMAN program is designed to
prevent, detect, and control
hypertension and other CVD risk factors
through healthy behavior support
services which are tailored for
individual and group behavior change.
The WISEWOMAN program provides
services to women who are jointly
enrolled in the National Breast and
Cervical Cancer Early Detection Program
(NBCCEDP), which is also administered
by CDC.
The WISEWOMAN program is
administered by state health
departments and tribal programs. In
2018, new five-year cooperative
agreements will be awarded under
Funding Opportunity Announcement
DP18–1816, subject to the availability of
funds. CDC collects two types of
information from WISEWOMAN
awardees. The WISEWOMAN awardee
submits an electronic data file to CDC
twice per year. The Minimum Data
Elements (MDE) file contains data using
a unique identifier with client-level
information about cardiovascular
disease risk factors, types of healthy
behavior support services for
participants served by the program. The
estimated burden per response for the
MDE file is 24 hours. The Annual
Progress Report provides a narrative
summary of each awardee’s objectives
and the activities undertaken to meet
program goals. The estimated burden
per response is 16 hours.
There are no changes to the
information collected. CDC will
continue to use the information
collected from WISEWOMAN awardees
to support program monitoring and
improvement activities, evaluation, and
assessment of program outcomes. The
overall program evaluation helps to
demonstrate program accomplishments
and strengthen the evidence for strategy
implementation for improved
engagement of underserved populations.
It can also determine whether the
identified strategies and associated
activities can be implemented at various
levels within a state or tribal
organization. Evaluation is also
designed to demonstrate how
WISEWOMAN can obtain
cardiovascular disease health outcome
data on at-risk populations, promote
public education about cardiovascular
disease risk-factors, and improve the
availability of healthy behavior support
services for under-served women.

E:\FR\FM\26DEN1.SGM

26DEN1

66270

Federal Register / Vol. 83, No. 246 / Wednesday, December 26, 2018 / Notices

OMB approval is requested for three
years. Participation in this information
collection is required as a condition of

cooperative agreement funding. There
are no costs to respondents other than

their time. The total annualized burden
hours are 1,344.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Average
burden per
response
(in hrs.)

Total burden
(in hrs.)

Form name

WISEWOMAN Awardees ..................

Screening and Assessment and
Lifestyle Program MDEs.
Annual Progress Report ...................

21

2

24

1,008

21

1

16

336

...........................................................

........................

........................

........................

1,344

Total ...........................................

Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2018–27855 Filed 12–21–18; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

E60, Atlanta, Georgia 30333, (404) 718–8833,
[email protected].
The Chief Operating Officer, Centers for
Disease Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.

Centers for Disease Control and
Prevention

[FR Doc. 2018–27893 Filed 12–21–18; 8:45 am]

Notice of Closed Meeting

BILLING CODE 4163–18–P

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.

amozie on DSK3GDR082PROD with NOTICES1

Number of
responses per
respondent

Type of respondents

Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—CK19–002,
Quantifying Contact Rates and Mixing
Patterns in Workers in Non-Healthcare Work
Settings in the United States and CK19–004,
Study to Assess the Risk of Blood Borne
Transmission of Classic Forms of CreutzfeldtJakob Disease (CJD).
Date: May 7, 2019.
Time: 10:00 a.m.–5:00 p.m., (EDT).
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Gregory
Anderson, M.S., M.P.H., Scientific Review
Officer, CDC, 1600 Clifton Road NE, Mailstop

VerDate Sep<11>2014

20:07 Dec 21, 2018

Jkt 247001

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–19–0600]

Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled CDC Model
Performance Evaluation Program
(MPEP) for Mycobacterium tuberculosis
Drug Susceptibility Testing to the Office
of Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on August
28, 2018 to obtain comments from the
public and affected agencies. CDC
received one non-substantive
anonymous comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:

PO 00000

Frm 00034

Fmt 4703

Sfmt 4703

(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to [email protected]. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
CDC Model Performance Evaluation
Program (MPEP) for Mycobacterium
tuberculosis Drug Susceptibility Testing
(OMB Control No.0920–0600, Expires 3/
31/2019)—Revision—National Center
for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention (NCHHSTP) Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
As part of the continuing effort to
support domestic public health

E:\FR\FM\26DEN1.SGM

26DEN1